Centre Publications

2020

Please click here for publications from previous years

Author(s) Title Year Citation
Sullivan SG, Carlson S, Cheng AC, Chilver MB, Dwyer DE, Irwin M, Kok J, Macartney K, MacLachlan J, Minney-Smith C, Smith D, Stocks N, Taylor J, Barr IG Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 2020 Euro Surveill. 2020 Nov;25(47) 
PubMed link
doi: 10.2807/1560-7917.ES.2020.25.47.2001847
Teh BW, Leung VKY, Mordant FL, Sullivan SG, Joyce T, Harrison SJ, Khvorov A, Barr IG, Subbarao K, Slavin MA, Worth LJ A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation 2020 Clin Infect Dis. 2020 Nov 11:ciaa1711 
PubMed link
doi: 10.1093/cid/ciaa1711
Khoury DS, Wheatley AK, Ramuta MD, Reynaldi A, Cromer D, Subbarao K, O'Connor DH, Kent SJ, Davenport MP Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models 2020 Nat Rev Immunol 2020 Nov 
PubMed link
doi: 10.1038/s41577-020-00471-1
Tosif S, Neeland MR, Sutton P, Licciardi PV, Sarkar S, Selva KJ, Do LAH, Donato C, Quan Toh Z, Higgins R, Van de Sandt C, Lemke MM, Lee CY, Shoffner SK, Flanagan KL, Arnold KB, Mordant FL, Mulholland K, Bines J, Dohle K, Pellicci DG, Curtis N, McNab S, Steer A, Saffery R, Subbarao K, Chung AW, Kedzierska K, Burgner DP, Crawford NW Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19 2020 Nat Commun. 2020 Nov 11;11(1):5703 
PubMed link
doi: 10.1038/s41467-020-19545-8
Lau YC, Perera RAPM, Fang VJ, Luk LH, Chu DKW, Wu P, Barr IG, Peiris JSM, Cowling BJ Variation by lineage in serum antibody responses to influenza B virus infections 2020 PLoS One. 2020 Nov 9;15(11):e0241693 
PubMed link
doi: 10.1371/journal.pone.0241693
Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG New technologies for influenza vaccines 2020 Nov 6;8(11):E1745 
PubMed link
doi:10.3390/microorganisms8111745
Zaraket H, Hurt AC, Clinch B, Barr I, Lee N Burden of influenza B virus infection and considerations for clinical management 2020 Antiviral Res. 2020 Nov 4:104970 
PubMed link
doi: 10.1016/j.antiviral.2020.104970
Subbarao K COVID-19 vaccines: time to talk about the uncertainties 2020 Nature 2020 Oct 
PubMed link
doi: 10.1038/d41586-020-02944-8
Subbarao K, Mordant F, Rudraraju R Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience 2020 Eur J Immunol. 2020 Oct 
PubMed link
doi: 10.1002/eji.202048723
Huddleston J, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Whittaker L, Ermetal B, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Barr I, Subbarao K, Barrat-Charlaix P, Neher RA, Bedford T Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution 2020 eLife Sep 2 
PubMed link
doi: 10.7554/eLife.60067
Wille M, Holmes EC Wild birds as reservoirs for diverse and abundant gamma- and deltacoronaviruses 2020 FEMS Microbiol Rev Sep 1  PubMed link
doi:10.1093/femsre/fuaa026
Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V, Jamrozik E, Kremsner PG, Lagos R, Pitisuttithum P, Plotkin SA, Sauerwein R, Shi SL, Sommerfelt H, Subbarao K, Treanor JJ, Vrati S, King D, Balasingam S, Weller C, Aguilar AO, Cassetti MC, Krause PR, Restrepo AMH Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers 2020 Clin Infect Dis Aug28 
PubMed link
doi: 10.1093/cid/ciaa1290
Bond K, Nicholson S, Lim SM, Karapanagiotidis T, Williams E, Johnson D, Hoang T, Sia C, Purcell D, Mordant F, Lewin SR, Catton M, Subbarao K, Howden BP, Williamson DA Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting 2020 J Infect Dis Aug 6 
PubMed link
doi: 10.1093/infdis/jiaa467
Jackson S, Peret TCT, Ziegler TT, Thornburg NJ, Besselaar T, Broor S, Barr I, Baumeister E, Chadha M, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Herring B, Herve K, Hirve S, Li Y, Pisareva M, Moen A, Naguib A, Palekar R, Potdar V, Siqueira M, Treurnicht F, Tivane A, Venter M, Wairagkar N, Zambon M, Zhang W Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17 2020 Influenza Other Respir Viruses Jul 30 
PubMed link
doi: 10.1111/irv.12771
Doerflinger M, Deng Y, Whitney P, Salvamoser R, Engel S, Kueh AJ, Tai L, Bachem A, Gressier E, Geoghegan ND, Wilcox S, Rogers KL, Garnham AL, Dengler MA, Bader SM, Ebert G, Pearson JS, De Nardo D, Wang N, Yang C, Pereira M, Bryant CE, Strugnell RA, Vince JE, Pellegrini M, Strasser A, Bedoui S, Herold MJ Flexible usage and interconnectivity of diverse cell death pathways protect against intracelllar infection 2020 Immunity Jul 19 
PubMed link
doi: 10.1016/j.immuni.2020.07.004
Sullivan SG The need for robust epidemiological evidence during a pandemic 2020 Clin Infect Dis Jun 16 
PubMed link
doi: 10.1093/cid/ciaa770
Juno JA, Tan HX, Lee WS, Reynaldi A, Kelly HG, Wragg K, Esterbauer R, Kent HE, Batten CJ, Mordant FL, Gherardin NA, Pymm P, Dietrich MH, Scott NE, Tham WH, Godfrey DI, Subbarao K, Davenport MP, Kent SJ, Wheatley AK Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 2020 Nat Med Jul 13  PubMed link
doi: 10.1038/s41591-020-0995-0
Wille M, Harvey E, Shi M, Gonzalez-Acuña D, Holmes EC and Hurt AC Sustained RNA virome diversity in Antarctic penguins and their ticks 2020 ISME J Apr 14  PubMed link
doi: 10.1038/s41396-020-0643-1
Koszalka P, Farrukee R, Mifsud E, Vijaykrishna D, Hurt AC A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions 2020 Influenza Other Respir Viruses 14:460-464  PubMed link
doi: 10.1111/irv.12725
Wille M, Holmes EC The Ecology and Evolution of Influenza Viruses2020Cold Spring Harb Perspect Med Jul 1;10(7):a038489  PubMed link
doi: 10.1101/cshperspect.a038489
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines 2020 Vaccine 38:4783-4791 
PubMed link
doi: 10.1016/j.vaccine.2020.05.064
Nüssing S, Mifsud E, Hensen L, Koutsakos M, Wang Z, Kedzierski L, Mercuri F, Rossignol JF, Hurt AC, Kedzierska K Viral burden, inflammatory milieu and CD8(+) T-cell responses to influenza virus in a second-generation thiazolide (RM-5061) and oseltamivir combination therapy study 2020 Influenza Other Respir Viruses Jun 25 
PubMed link
doi: 10.1111/irv.12776
Xia J, Adam DC, Moa A, Chughtai AA, Barr IG, Komadina N, MacIntyre CR Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017 2020 Influenza Other Respir Viruses Jun 17 
PubMed link
doi: 10.1111/irv.12772
Subbarao K, Mahanty S Respiratory Virus Infections: Understanding COVID-19 2020 Immunity Jun 16;52(6):905-909 
PubMed link
doi: 10.1016/j.immuni.2020.05.004
Tilmanis D, Koszalka P, Barr IG, Rossignol JF, Mifsud E, Hurt AC Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir. 2020 Antiviral Res 180:104851 
PubMed link
doi: 10.1016/j.antiviral.2020.104851
Lam EKS, Morris DH, Hurt AC, Barr IG and Russell CA The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia 2020 Nat Commun Jun 2;11(1):2741 
PubMed link
doi: 10.1038/s41467-020-16545-6
Hoa LNM, Sullivan SG, Mai LQ, Khvorov A, Phuong HVM, Hang NLK, Thai PQ, Thanh LT, Carolan L, Anh DD, Duong TN, Bryant JE, van Doorn HR, Wertheim HFL, Horby P, Fox A Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort 2020 J Infect Dis Jun 2;jiaa293 
PubMed link
doi: 10.1093/infdis/jiaa293
Farrukee R, Tai CM, Oh DY, Anderson DE, Gunalan V, Hibberd M, Lau GY, Barr IG, Messling VV, Maurer-Stroh S, Hurt AC Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility 2020 PLoS Pathog 16:e1008592 
PubMed link
doi: 10.1371/journal.ppat.1008592
Barr IG, Rynehart C, Whitney P, Druce J SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines 2020 Euro Surveill 25 
PubMed link
doi: 10.2807/1560-7917.ES.2020.25.25.2001122
Weinman AL, Sullivan SG, Vijaykrishna D, Markey P, Levy A, Miller A and Tong SYC Epidemiological trends in notified influenza cases in Australia's Northern Territory, 2007-2016 2020 Influenza Other Respir Viruses May 23 
PubMed link
doi: 10.1111/irv.12757
Bedford JG, Infusini G, Dagley LF, Villalon-Letelier F, Zheng MZM, Bennett-Wood V, Reading PC and Wakim LM Airway Exosomes Released During Influenza Virus Infection Serve as a Key Component of the Antiviral Innate Immune Response 2020 Front Immunol May 12;11:887  PubMed link
doi: 10.3389/fimmu.2020.00887
Rockman S, Laurie K, Barr I Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now? 2020 Vaccines 8(2):E211  PubMed link
doi: 10.1371/journal.ppat.1008395
Meischel T, Villalon-Letelier F, Saunders PM, Reading PC and Londrigan SL Influenza A virus interactions with macrophages: Lessons from epithelial cells 2020 Cell Microbiol May;22(5):e13170  PubMed link
doi: 10.1111/cmi.13170
Marcelino VR, Clausen P, Buchmann JP, Wille M, Iredell JR, Meyer W, Lund O, Sorrell TC, Holmes EC CCMetagen: comprehensive and accurate identification of eukaryotes and prokaryotes in metagenomic data 2020 Genome Biol 21:103  PubMed link
doi: 10.1186/s13059-020-02014-2
Ryan AL, Wadia UD, Jacoby P, Cheung LC, Kerr F, Fraser C, Tapp H, Mechinaud F, Carolan LA, Laurie KL, Barr IG, Blyth CC, Gottardo NG, Richmond PC and Kotecha RS Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant 2020 Bone Marrow Transplant 55(4):773-779 
PubMed link
doi: 10.1038/s41409-019-0728-5
Mifsud EJ, Tilmanis D, Oh DY, Ming-Kay Tai C, Rossignol JF and Hurt AC Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy 2020 Antiviral Res Apr;176:104751 
PubMed link
doi: 10.1016/j.antiviral.2020.104751
Lee LYY, Zhou J, Frise R, Goldhill DH, Koszalka P, Mifsud EJ, Baba K, Noda T, Ando Y, Sato K, Yuki AI, Shishido T, Uehara T, Wildum S, Zwanziger E, Collinson N, Kuhlbusch K, Clinch B, Hurt AC and Barclay WS Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission 2020 PLoS Pathog Apr 15;16(4):e1008395 
PubMed link
doi: 10.1371/journal.ppat.1008395
Subbarao K Live attenuated influenza vaccines for pandemic preparedness 2020 J Pediatric Infect Dis Soc 19;9(Supplement_1):S15-S18 
PubMed link
doi: 10.1093/jpids/piz073
Chadha M, Hirve S, Bancej C, Barr I, Baumeister E, Caetano B, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Kadjo H, Jackson S, Leung V, Pisareva M, Moyes J, Naguib A, Tivane A, Zhang W, Group WRS Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance 2020 Influenza Other Respir Viruses Mar 12 
PubMed link
doi: 10.1111/irv.12726
Lim WW, Leung NHL, Sullivan SG, Tchetgen Tchetgen EJ and Cowling BJ Distinguishing causation from correlation in the use of correlates of protection to evaluate and develop influenza vaccines 2019 Am J Epidemiol 189(3):185-192 
PubMed link
doi: 10.1093/aje/kwz227
Takashita E, Daniels RS, Fujisaki S, Gregory V, Gubareva LV, Huang W, Hurt AC, Lackenby A, Nguyen HT, Pereyaslov D, Roe M, Samaan M, Subbarao K, Tse H, Wang D, Yen HL, Zhang W and Meijer A Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018 2020 Antiviral Res Mar;175:104718 
PubMed link
doi: 10.1016/j.antiviral.2020.104718
Vanderven HA, Barr I, Reynaldi A, Wheatley AK, Wines BD, Davenport MP, Hogarth PM and Kent SJ Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults 2020 Vaccine Feb 28;38(10):2368-2377 
PubMed link
doi: 10.1016/j.vaccine.2020.01.066
Londrigan SL, Wakim LM, Smith J, Haverkate AJ, Brooks AG and Reading PC IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages 2020 Virology Jan 15;540:17-22 
PubMed link
doi: 10.1016/j.virol.2019.11.003
Hung SJ, Hsu YM, Huang SW, Tsai HP, Lee LYY, Hurt AC, Barr IG, Shih SR and Wang JR Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation 2020 J Biomed Sci 6;27(1):17 
PubMed link
doi: 10.1186/s12929-019-0612-z
Wille M Unravelling virus community ecology in bats through the integration of metagenomics and community ecology 2020 Mol Ecol Jan;29(1):23-25 
PubMed link
doi: 10.1111/mec.15306
Deng YM, Wong FYK, Spirason N, Kaye M, Beazley R, Grau MLL, Shan S, Stevens V, Subbarao K, Sullivan S, Barr IG, Dhanasekaran V. Locally Acquired Human Infection with Swine-Origin Influenza A(H3N2) Variant Virus, Australia, 2018. 2020 Emerg Infect Dis Jan;26(1):143-147 
PubMed link
doi: 10.3201/eid2601.191144
Chua H, Feng S, Lewnard JA, Sullivan SG, Blyth CC, Lipsitch M and Cowling BJ The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology 2020 Epidemiology Jan;31(1):43-64 
PubMed link
doi: 10.1097/EDE.0000000000001116

Top of Page